The pharmacology of oral agents used to treat diabetes mellitus
โ Scribed by Chan, A W ;Macfarlane, I A
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 860 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1357-8170
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Review: 24 refs.
Background Both HMG-CoA reductase inhibitors and ยฎbric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg bezaยฎbrate, a ยฎbric acid deriva
## Abstract Quality of life, glycaemic control and frequency of hypoglycaemia were compared in 93 moderate to poorly controlled Type 2 diabetes patients randomly allocated to one of three treatment groups: Group A continued on oral hypoglycaemics, Group B switched to twiceโdaily fixed mixture of hu